Download PDF
Int J Sports Med 2000; 21(4): 256-262
DOI: 10.1055/s-2000-8884
Physiology and Biochemistry
Georg Thieme Verlag Stuttgart ·New York

Interactions between Homocyst(e)ine and Nitric Oxide During Acute Submaximal Exercise in Adult Males[1]

C. De Crée2 , P. H. Whiting3 , H. Cole4
  • 2 Physiology of Exercise Unit, School of Physical Education, Sport and Leisure, De Montfort University, Bedford, UK
  • 3 Department of Pharmaceutical Sciences, School of Applied Sciences, De Montfort University, Leicester, UK
  • 4 Respro Ltd., London, UK
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Also available at
    Permissions and Reprints

Experimental studies investigating the effects of exercise on plasma total homocyst(e)ine (H[e]) levels in humans are almost non-existent. H(e) has been demonstrated to represent an independent risk factor for cardiovascular disease. The exact mechanism through which H(e) exerts its effects on the arteries is unknown but it is thought to involve nitric oxide (NO). The present study was designed to assess the effects of acute submaximal exercise on H(e) while levels of NO inhalation were manipulated using an air-filter mask. The study was completed by seven male volunteers, aged 21.6 ± 1.3 yr (X¯ ± SD), V˙O2max: 48.6 ± 7.6 mL × kg−1 × min−1. During two separate occasions the subjects performed a 1-hour bout of submaximal exercise on a stationary cycle ergometer at 60 % of their V˙O2max. The two trials were completed in random order (with and without mask). Data were collected before (PRE) and after (POST) the acute exercise bouts. Plasma H(e) was directly measured by HPLC and NO by quantifying the enzymatic oxidation to nitrite (NO2 −) & nitrate (NO3 −). Mean H(e) concentrations were 10.89 ± 2.05 nmol/mL (PRE) & 11.21 ± 1.81 nmol/mL (POST) and were not significantly altered by submaximal exercise. When wearing a mask, the correlation of the PRE/POST H(e) differences with the PRE/POST differences in NO3 − were 0.77 (P = 0.07). No correlation was found between either H(e) and NO2 − or between NO2 − and NO3 −. However, a significant correlation (r = − 0.86, P = 0.03) was also observed between H(e) and NO2 − but only for the post-exercise values when wearing a mask. The results suggest that: (1) plasma H(e) levels are not affected by acute submaximal exercise; (2) there is insufficient evidence to support the view that plasma H(e) levels are being mediated by NO during either rest or exercise.

Key words:

Amino acids - cardiovascular disease - homocysteine - nitric oxide

01 Presented in part at the 46th Annual Meeting of the American College of Sports Medicine, Seattle, WA, June 2 to 5, 1999 (Session C-32).

References

  • 01 Altman J D, Kinn J, Duncker D J. Effect of inhibition of nitric oxide formation on coronary blood flow during exercise in the dog.  Cardiovasc Res. 1994;  28 119-124
    Google Scholar
  • 02 Blundell G, Jones B G, Rose F A. Homocysteine mediated endothelial cell toxicity and its amelioration.  Atherosclerosis. 1996;  122 163-172
    Google Scholar
  • 03 Brattström L, Lindgren A, Israelsson B. Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke factors.  Eur J Clin Invest. 1992;  22 214-221
    Google Scholar
  • 04 Celermajer D S, Sorensen K, Ryalls M. Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents.  J Am Coll Cardiol. 1993;  22 854-858
    Google Scholar
  • 05 De Crée C, Malinow M R, Van Kranenburg G, Geurten P, Longford N T, Keizer H A. Influence of exercise and menstrual cycle phase on plasma homocyst(e)ine levels in premenopausal women. - A prospective study.  Scand J Med Sci Sport. 1999;  9 272-278
    Google Scholar
  • 06 de Groot P G, Willems C, Boers G H. Endothelial dysfunction in homocystinuria.  Eur J Clin Invest. 1983;  13 405-410
    Google Scholar
  • 07 Delp M D, Laughlin M H. Regulation of skeletal muscle perfusion during exercise.  Acta Physiol Scand. 1998;  162 411-419
    Google Scholar
  • 08 Dill D B, Costill D L. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration.  J Appl Physiol. 1974;  37 247-248
    Google Scholar
  • 09 Franks B D, Huck S W. Why does everyone use the .05 significance level?.  Res Q Exerc Sport. 1986;  57 245-249
    Google Scholar
  • 10 Gallagher P M, Meleady R, Shields D C. Homocysteine and risk of premature coronary disease: evidence for a common gene mutation.  Circulation. 1996;  94 2154-2158
    PubMedGoogle Scholar
  • 11 Harker L A, Slichter S J, Scott C R. Homocystine-induced arteriosclerosis: the role of endothelial cell injury and platelet response in its genesis.  J Clin Invest. 1976;  58 731-741
    PubMedGoogle Scholar
  • 12 Honig C R. Contributions of nerves and metabolites to exercise vasodilation: a unifying hypothesis.  Am J Physiol. 1979;  236 719
    PubMedGoogle Scholar
  • 13 Ignarro L, Murad F. Nitric oxide. Biochemistry molecular biology, and therapeutic implications. In: Ignarro, L, Murad, F (eds) Advances in pharmacology series. San Diego, CA; Academic Press, Inc. 1995: 1-516
    Google Scholar
  • 14 Kang S-S, Wong P W, Malinow M R. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease.  Annu Rev Nutr. 1992;  12 279-298
    Google Scholar
  • 15 Koller-Strametz J, Mattulla B, Wolzt M. Role of nitric oxide in exercise-induced vasodilatation in man.  Life Sci. 1998;  62 1035-1042
    CrossrefPubMedGoogle Scholar
  • 16 Kraus R M. Exercise, lipoproteins, and coronary artery disease.  Circulation. 1989;  79 1143-1145
    PubMedGoogle Scholar
  • 17 Kuo L, Davis M J, Chilian W M. Endothelium-dependent, flow-induced dilation of isolated coronary arterioles.  Am J Physiol. 1988;  259 1324
    PubMedGoogle Scholar
  • 18 Lane N P, Whiting P H, Cole H, De Crée C. The effects of a sports anti-pollution mask on pulmonary function and free radical formation during sub-maximal exercise (Abstract).  Br J Sports Med. 1999;  33 59
    PubMedGoogle Scholar
  • 19 Laughlin M H. Skeletal muscle blood flow capacity: role of muscle pump in exercise hyperemia.  Am J Physiol. 1987;  253 1004
    PubMedGoogle Scholar
  • 20 Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia.  J Clin Invest. 1996;  98 5-7
    CrossrefPubMedGoogle Scholar
  • 21 Malinow M R. Homocysteine and arterial occlusive diseases.  J Int Med. 1994;  236 603-617
    PubMedGoogle Scholar
  • 22 Malinow M R, Duell P B, Hess D L. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease.  N Engl J Med. 1998;  338 1009-1015
    CrossrefPubMedGoogle Scholar
  • 23 Malinow M R, Kang S S, Taylor L M. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease.  Circulation. 1989;  79 1180-1188
    Google Scholar
  • 24 Maxwell A J, Schauble E, Bernstein D. Limb blood flow during exercise is dependent on nitric oxide.  Circulation. 1988;  98 369-374
    PubMedGoogle Scholar
  • 25 McAllister R M, Hirai T, Musch T L. Contribution of endothelium-derived nitric oxide (EDNO) to the skeletal muscle blood flow response to exercise.  Med Sci Sport Exerc. 1995;  27 1145-1151
    PubMedGoogle Scholar
  • 26 McCully K S. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.  Am J Pathol. 1969;  56 111-128
    Google Scholar
  • 27 Nygård O, Vollset S E, Refsum H. Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteine study.  JAMA. 1995;  274 1526-1533
    CrossrefPubMedGoogle Scholar
  • 28 Ray J G. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease.  Arch Intern Med. 1998;  158 2101-2106
    CrossrefPubMedGoogle Scholar
  • 29 Ross R. The pathogenesis of atherosclerosis - An update.  N Engl J Med. 1986;  314 488-500
    CrossrefPubMedGoogle Scholar
  • 30 Scheuer J, Tipton C M. Cardiovascular adaptations to physical training.  Ann Rev Physiol. 1977;  39 221-251
    PubMedGoogle Scholar
  • 31 Stamler J S, Osborne J A, Jaraki O. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.  J Clin Invest. 1993;  91 308-318
    PubMedGoogle Scholar
  • 32 Starkebaum G, Harlan J M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.  J Clin Invest. 1986;  77 1370-1376
    CrossrefPubMedGoogle Scholar
  • 33 Stein J H, McBride P E. Hyperhomocysteinemia and atherosclerotic vascular disease.  Arch Intern Med. 1998;  158 1301-1306
    CrossrefPubMedGoogle Scholar
  • 34 Stefanick M L, Mackey S, Sheehan M. Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol.  N Engl J Med. 1998;  339 12-20
    CrossrefPubMedGoogle Scholar
  • 35 Thune I, Njølstad I, Løchen M-J. Physical activity improves the metabolic risk profiles in men and women.  Arch Intern Med. 1998;  158 1633-1640
    CrossrefPubMedGoogle Scholar
  • 36 Ueland P M, Refsum H. Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy.  J Lab Clin Med. 1989;  114 473-501
    Google Scholar
  • 37 Upchurch G R Jr, Welch G N, Fabian A J. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase.  J Biol Chem. 1997;  272 17012-17017
    CrossrefPubMedGoogle Scholar
  • 38 Weiss M, Schmid A, Baum M. Influence of extensive exercise on plasma amino acids and plasma homocysteine (Abstract).  Int J Sports Med. 1998;  19 52
    PubMedGoogle Scholar
  • 39 Wild R A. Obesity, lipids, cardiovascular risk, and androgen excess.  Am J Med. 1995;  98 27
    CrossrefPubMedGoogle Scholar
  • 40 Wilson J R, Kapoor S. Contribution of endothelium-derived relaxing factor to exercise-induced vasodilation in humans.  J Appl Physiol. 1993;  75 2740-2744
    PubMedGoogle Scholar
  • 41 Wright M, Francis K, Cornwell Ph. Effect of acute exercise on plasma homocysteine.  J Sports Med Phys Fitness. 1998;  38 262-265
    PubMedGoogle Scholar

01 Presented in part at the 46th Annual Meeting of the American College of Sports Medicine, Seattle, WA, June 2 to 5, 1999 (Session C-32).

Dr. C. De Crée

P. O. Box 120

1930 Zaventem 4

Belgium

Email: cdecree@skynet.be

      >